Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 209,361 | 188,000 | 177,757 | 181,949 | 159,301 |
| Cost of Goods | 80,190 | 79,616 | 80,433 | 83,661 | 62,507 |
| Gross Profit | 129,171 | 108,384 | 97,324 | 98,288 | 96,794 |
| Operating Expenses | 67,274 | 73,895 | 76,070 | 60,838 | 62,462 |
| Operating Income | 62,087 | 35,105 | 21,687 | 38,111 | 34,839 |
| Interest Expense | 21,767 | 20,463 | 20,790 | 22,654 | 18,394 |
| Other Income | 3,116 | 2,383 | 2,225 | 1,812 | -865 |
| Pre-tax Income | 43,436 | 17,025 | 3,122 | 17,269 | 15,580 |
| Income Tax | 11,929 | 5,042 | 705 | 4,733 | 6,245 |
| Net Income Continuous | 31,507 | 11,983 | 2,417 | 12,536 | 9,335 |
| Net Income | $31,507 | $11,983 | $2,417 | $12,536 | $9,335 |
| EPS Basic Total Ops | 1.00 | 0.38 | 0.08 | 0.39 | 0.29 |
| EPS Basic Continuous Ops | 1.00 | 0.38 | 0.08 | 0.39 | 0.29 |
| EPS Diluted Total Ops | 0.84 | 0.34 | 0.07 | 0.36 | 0.27 |
| EPS Diluted Continuous Ops | 0.80 | 0.31 | 0.07 | 0.32 | 0.23 |
| EPS Diluted Before Non-Recurring Items | 2.06 | 1.47 | 1.23 | 1.63 | 1.48 |
| EBITDA(a) | $118,363 | $91,449 | $77,927 | $94,247 | $76,072 |